Clinical Trial: A Safety Study of LBH589 (Panobinostat) and RAD001 (Everolimus) to Stabilize Kidney Cancer
Sponsor and Collaborators
Roswell Park Cancer Institute
Contact: Roswell Park Cancer Institute
Roberto Pili, MD Roswell Park Cancer Institute
Next post in Kidney Cancer Clinical Trials
Log in to continue reading this article.
Don’t miss out on today’s top content on Oncology Nurse Advisor. Register for free and gain unlimited access to:
- Clinical Updates
- Evidence-Based Guidance
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
Want to read more?
Please login or register first to view this content.